A Phase 2 interventional study of diclofenac sodium and dexotc in Otitis Externa, sponsored by Sieff Medical Center. Terminated at 1 site in Israel. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-04-20.
Sponsored by Sieff Medical Center · Phase 2, Interventional, and Treatment
Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.
anticipated advantages are: reduction of inflammation and edema, no fungal overpopulation- when steroids are employed, contains boric acid as an ingredient, high safety profile, can be switched to antibiotic therapy later, can be used in conjunction wit steroids
22 studies on the registry are indexed under Otitis Externa; 1 is open to participants now.
This study's enrollment of 20 is below the median of 100 across 20 interventional studies indexed under Otitis Externa.
Browse Otitis Externa studies →This is the only study on the registry with Sieff Medical Center as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
voltaren ophta
Drug: diclofenac sodium
dexotic
Drug: dexotc
topical solution used in ear 5 drops 8 3/day
Also known as: voltaren ophta
aural drops
Also known as: dexotic
reducing oral analagestic use
Time frame: 1 week
adding an alternative treatment for otitis externa
Time frame: 1 week
This study is terminated, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Diclofenac